Vascular calcification (VC) is prevalent in aging, and patients with hypertension, chronic kidney disease (CKD) or diabetes. VC is regarded as an active and complex process that involves multiple mechanisms responsible for calcium deposition in vessel wall. In light of the complicated pathogenesis of VC, effective therapy for ameliorating VC is limited. Thus, it is urgent to explore the potential mechanisms and find new targets for the therapy of VC. Platelet‐derived growth factor (PDGF), a potent mitogen and chemoattractant, has been found to disturb the vascular homeostasis by inducing inflammation, oxidative stress and phenotype transition, all of which accelerate the process of VC. The aim of current review is to present a review about the roles of PDGF in affecting VC and to establish a potential target for treating VC. This article is protected by copyright. All rights reserved